Abstract:Worldwide, cancer is a huge burden, and each year sees an increase in its incidence. RAB (Ras-related in brain) 13 is crucial for a number of tumor types. But more research on RAB13's tumor-related mechanism is still required. This study's goal was to investigate RAB13's function in human pan-cancer, and we have also preliminarily explored the relevant mechanisms. To investigate the differential expression, survival prognosis, immunological checkpoints, and pathological stage of RAB13 in human pan-cancer, respectively, databases of TIMER2.0, GEPIA 2, and UALCAN were employed. CBioPortal database was used to analyze the mutation level, meanwhile, PPI network was constructed based on STRING website. The putative functions of RAB13 in immunological infiltration were investigated using single sample gene set enrichment analysis (ssGSEA). The mechanism of RAB13 in hepatocellular cancer was also briefly investigated by us using gene set enrichment analysis (GSEA). RAB13 was differentially expressed in a number of different cancers, including liver hepatocellular carcinoma (LIHC), stomach adenocarcinoma (STAD), etc. Additionally, RAB13 overexpression in LGG and LIHC is associated with a worse prognosis, including overall survival (OS) and disease-free survival (DFS). Then, we observed that early in BLCA, BRAC, CHOL, ESCA, HNSC, KICH, KIRC, LIHC, LUAD, LUSC, and STAD, the level of RAB13 expression was raised. Next, we found that "amplification" was the most common mutation in RAB13 . The expression of SLC39A1, JTB, SSR2, SNAPIN, and RHOC was strongly positively linked with RAB13, according to a correlation study. RAB13 favorably regulated B cell, CD8 + T cell, CD4 + T cell, macrophage, neutrophil, and dendritic cell in LIHC, according to immune infiltration analysis. Immune checkpoint study revealed a positive correlation between RAB13 expression and PD1, PDL1, and CTLA4 in LIHC. According to GSEA, RAB13 is involved in a number of processes in LIHC, including MTORC1 signaling, MYC targets v1, G2M checkpoint, MITOTIC spindle, DNA repair, P53 pathway, glycolysis, PI3K-AKT-MTOR signaling, etc. RAB13 is a possible therapeutic target in LIHC and can be used as a prognostic marker.

High Expression of RAB43 Predicts Poor Prognosis and is Associated with Epithelial-Mesenchymal Transition in Gliomas.

Overexpression of RAB34 Associates with Tumor Aggressiveness and Immune Infiltration in Glioma

RAB42 Promotes Glioma Pathogenesis via the VEGF Signaling Pathway

High Expression of RAB32 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioblastoma

Increased RLIP76 Expression in IDH1 Wild‑type Glioblastoma Multiforme is Associated with Worse Prognosis

RAB1A Regulates Glioma Cellular Proliferation and Invasion Via the Mtor Signaling Pathway and Epithelial-Mesenchymal Transition.

The Progression Related Gene RAB42 Affects the Prognosis of Glioblastoma Patients

RAB42 overexpression correlates with poor prognosis, immune cell infiltration and chemoresistance

Rab32 promotes glioblastoma migration and invasion via regulation of ERK/Drp1-mediated mitochondrial fission

RAB32 promotes glioma cell progression by activating the JAK/STAT3 signaling pathway

Elevated GAS2L3 Expression Correlates with Poor Prognosis in Patients with Glioma: A Study Based on Bioinformatics and Immunohistochemical Analysis

RabGEF1 Functions As an Oncogene in U251 Glioblastoma Cells and is Involved in Regulating AKT and Erk Pathways

Pan-Cancer Analysis of the Roles and Driving Forces of RAB42

The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer

Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis

CS-27 * IDH1/2 MUTATIONS INFLUENCE ZEB1 EXPRESSION IN GRADES II AND III GLIOMAS

Expression of neuropilin-1 is linked to glioma associated microglia and macrophages and correlates with unfavorable prognosis in high grade gliomas

High Expression of Rab3D Predicts Poor Prognosis and Associates with Tumor Progression in Colorectal Cancer.

High myosin binding protein H expression predicts poor prognosis in glioma patients

Mir-200B As a Prognostic Factor Targets Multiple Members of RAB Family in Glioma

Rab 13 silencing causes inhibition of growth and induction of apoptosis in human glioma cells